Comparative mutational landscape analysis of patient-derived tumour xenografts-Reference-Cited by-同舟云学术

Comparative mutational landscape analysis of patient-derived tumour xenografts

Published:2017-01-24 Issue:4 Volume:116 Page:515-523
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Brait Mariana,Izumchenko Evgeny,Kagohara Luciane T,Long Samuel,Wysocki Piotr T,Faherty Brian,Fertig Elana J,Khor Tin Oo,Bruckheimer Elizabeth,Baia Gilson,Ciznadija Daniel,Sloma Ido,Ben-Zvi Ido,Paz Keren,Sidransky David

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/bjc2016450.pdf

Reference49 articles.

1. Anastas JN, Moon RT (2013) WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer 13 (1): 11–26.

2. Ascierto PA, Simeone E, Giannarelli D, Grimaldi AM, Romano A, Mozzillo N (2012) Sequencing of BRAF inhibitors and ipilimumab in patients with metastatic melanoma: a possible algorithm for clinical use. J Transl Med 10: 107.

3. Bertotti A, Migliardi G, Galimi F, Sassi F, Torti D, Isella C, Cora D, Di Nicolantonio F, Buscarino M, Petti C, Ribero D, Russolillo N, Muratore A, Massucco P, Pisacane A, Molinaro L, Valtorta E, Sartore-Bianchi A, Risio M, Capussotti L, Gambacorta M, Siena S, Medico E, Sapino A, Marsoni S, Comoglio PM, Bardelli A, Trusolino L (2011) A molecularly annotated platform of patient-derived xenografts (‘xenopatients’) identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer. Cancer Discov 1 (6): 508–523.

4. Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, Antonarakis ES, Azad NS, Bardelli A, Brem H, Cameron JL, Lee CC, Fecher LA, Gallia GL, Gibbs P, Le D, Giuntoli RL, Goggins M, Hogarty MD, Holdhoff M, Hong SM, Jiao Y, Juhl HH, Kim JJ, Siravegna G, Laheru DA, Lauricella C, Lim M, Lipson EJ, Marie SK, Netto GJ, Oliner KS, Olivi A, Olsson L, Riggins GJ, Sartore-Bianchi A, Schmidt K, Shih LM, Oba-Shinjo SM, Siena S, Theodorescu D, Tie J, Harkins TT, Veronese S, Wang TL, Weingart JD, Wolfgang CL, Wood LD, Xing D, Hruban RH, Wu J, Allen PJ, Schmidt CM, Choti MA, Velculescu VE, Kinzler KW, Vogelstein B, Papadopoulos N, Diaz LA Jr. (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 6 (224): 224ra24.

5. Bolton L, Reiman A, Lucas K, Timms J, Cree IA (2015) KRAS mutation analysis by PCR: a comparison of two methods. PLoS One 10 (1): e0115672.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the Current Landscape of Kidney Disease in Canada to Advance Precision Medicine Guided Personalized Care;Canadian Journal of Kidney Health and Disease;2023-01

2. Digital PCR: Methods and applications in infectious diseases;Methods;2022-05

3. SARS-CoV-2 Subgenomic RNAs: Characterization, Utility, and Perspectives;Viruses;2021-09-24

4. Ultrasensitive detection and quantification of viral nucleic acids with Raindance droplet digital PCR (ddPCR);Methods;2021-05

5. In pursuit of sensitivity: Lessons learned from viral nucleic acid detection and quantification on the Raindance ddPCR platform;Methods;2021-04